Hitachi Ltd. will withdraw its plan to build a $28 billion nuclear power plant in the UK as it is unlikely that the British government will provide additional support.
The project, which consists of building two nuclear reactors on the island of Anglesey, was suspended in January 2019 due to difficulty in securing funds.
The decision is still to be finalized by the company's board.
Hitachi did not rule out the possibility of reviving the project if additional funding support would be provided.
The project's cost increased one and a half times the original estimate to 3 trillion yen due to safety features.
Stalled negotiations with the British government for funding were attributed to the pandemic and the Brexit.
Hitachi's withdrawal is another blow to Japan's efforts to promote infrastructure exports as a key economic growth driver.
Toshiba Corp., another Japanese company, has withdrawn from its US nuclear power business.


Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
Stellantis Sells Free2move Car-Sharing Business to Mutares to Strengthen Core Auto Strategy
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth 



